Tissue microarrays for rapid linking of molecular changes to clinical endpoints

American Journal of Pathology

Volumn 159, Issue 6, 2001, Pages 2249-2256

  Torhorst, Joachim ^a   Bucher, Christoph ^a   Kononen, Juha ^c   Haas, Philippe ^a   Zuber, Markus ^a   Köchli, Ossi R ^b   Mross, Frank ^d   Dieterich, Holger ^e   Moch, Holger ^a   Mihatsch, Michael ^a   Kallioniemi, Olli P ^c   Sauter, Guido ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY WOMEN S HOSPITAL   (Switzerland)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^d Kreiskrankenhaus   (Germany)

^e Thurgauisches K   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; PROTEIN P53;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER SURVIVAL; DISEASE MARKER; DNA MICROARRAY; FEMALE; GENETIC HETEROGENEITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROGNOSIS; TUMOR BIOPSY;

EID: 0035180732     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63075-1     Document Type: Article

References (27)

1. Prognostic and predictive factors in breast cancer by immunohistochemical analysis
2. Prognostic usefulness of estrogen receptor immunocytochemical assays for human breast cancer
3. Association of c-erbB-2 protein over-expression with high rate of cell proliferation, increased risk of visceral metastasis, and poor long-term survival in breast cancer
4. Genetic alterations in c-erbB-2 protooncogene as prognostic markers in human primary breast tumors
5. Immunocytochemical estrogen and progestin receptor assays in breast cancer with monoclonal antibodies; Histopathologic, demographic, and biochemical correlations and relationship to endocrine response and survival
6. Comparison of two estrogen receptor assays in the prediction of the clinical course of patients with advanced breast cancer
7. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene
8. HER2/neu oncogene protein and prognosis in breast cancer
9. Expression profiling using cDNA microarrays
10. Tissue microarrays for high-throughput molecular profiling of tumor specimens
11. The multitumor (sausage) tissue block: Novel method for immunohistochemical antibody testing
12. Pathological prognostic factors in breast cancer, I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up
13. Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients
14. Accumulation of p53 tumor suppressor gene protein: An independent marker of prognosis in breast cancers
15. Tumor heterogeneity of DNA cell cycle variables in breast cancer measured by flow cytometry
16. Tumor-antigen heterogeneity of disseminated breast cancer cells: Implications for immunotherapy of minimal residual disease
17. Influence of tissue heterogeneity on the determination of steroid receptors in breast cancer
18. Intratumoral heterogeneity of von Hippel-Lindau gene deetions in renal cell carcinoma detected by fluorescence in situ hybridization
19. Heterogeneity in hormone receptor status in primary and metastatic breast cancer
20. Heterogeneity of intratumour proliferative activity in primary breast cancer: Biological and clinical aspects
21. Human breast cancer: Heterogeneity of estrogen binding sites
22. Breast cancer heterogeneity: Evaluation of clonality in primary and metastatic lesions
23. Tissue microarrays for gene amplification surveys in many different tumor types
24. High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma
25. Bcl-2 and p53 expression in node-negative breast carcinoma: A study with long-term follow-up
26. Lack of prognostic value of p53 protein expression in node-negative breast cancer
27. p53 protein expression in human breast carcinoma: Lack of prognostic potential for recurrence of the disease